National Human Genome Research Institute; Notice of Meeting, 47715-47716 [2013-18894]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 151 / Tuesday, August 6, 2013 / Notices
https://bloodcell.transplant.hrsa.gov/
ABOUT/Advisory_Council/.
The draft meeting agenda will be
posted on https://
www.acbsctmeeting.com. Those
participating in this meeting should
register by visiting https://
www.acbsctmeeting.com. The deadline
to register for this meeting is
Wednesday, September 11, 2013. For all
logistical questions and concerns, please
contact Deborah Jones, Meeting Planner,
by calling (301) 585–1261 or by sending
an email to Deborah.Jones@luxcg.com.
The public can join the meeting by:
1. (Audio Portion) Calling the
conference number at 800–857–9638
and providing the Participant Code
75841, AND
2. (Visual Portion) Connecting to the
ACBSCT Adobe Connect Pro Meeting
using the following URL and entering as
GUEST: https://
hrsa.connectsolutions.com/
acbsct_advisory/ (copy and paste the
link into your browser if it does not
work directly, and enter as a guest).
Participants should call and connect
15 minutes prior to the meeting in order
for logistics to be set up. If you have
never attended an Adobe Connect
meeting, please test your connection
using the following URL: https://
hrsa.connectsolutions.com/common/
help/en/support/meeting_test.htm and
get a quick overview by following URL:
https://www.adobe.com/go/
connectpro_overview.
Call (301) 443–0437 or send an email
to ptongele@hrsa.gov if you are having
trouble connecting to the meeting site.
Public Comment: It is preferred that
persons interested in providing an oral
presentation submit a written request,
along with a copy of their presentation
to: Passy Tongele, MBA, Division of
Transplantation, Healthcare Systems
Bureau, Health Resources and Services
Administration, Room 12C–06, 5600
Fishers Lane, Rockville, Maryland
20857 or email at ptongele@hrsa.gov.
Requests should contain the name,
address, telephone number, email
address, and any business or
professional affiliation of the person
desiring to make an oral presentation.
Groups having similar interests are
requested to combine their comments
and present them through a single
representative.
The allocation of time may be
adjusted to accommodate the level of
expressed interest. Persons who do not
file an advance request for a
presentation, but desire to make an oral
statement, may request it at the time of
the public comment period. Public
participation and ability to comment
will be limited to time as it permits.
VerDate Mar<15>2010
19:47 Aug 05, 2013
Jkt 229001
For Further Information Contact:
Patricia Stroup, MBA, MPA, Executive
Secretary, Healthcare Systems Bureau,
Health Resources and Services
Administration, 5600 Fishers Lane,
Room 12C–06, Rockville, Maryland
20857; telephone (301) 443–1127.
Dated: July 30, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–18825 Filed 8–5–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee
Date: September 12, 2013.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
509, 5635 Fishers Lane, Bethesda, MD 20892.
Contact Person: Camilla E. Day, Ph.D.,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
4075, Bethesda, MD 20892, 301–402–8837,
camilla.day@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research,
National Institutes of Health, HHS)
Dated: July 31, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–18896 Filed 8–5–13; 8:45 am]
Frm 00046
Fmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Environmental
Health Sciences Review Committee, July
24, 2013, 08:00 a.m. to July 26, 2013,
02:00 p.m., Double Tree by Hilton, 4810
Page Creek Lane, Ball Room, Durham,
NC, 27703 which was published in the
Federal Register on July 02, 2013, 2013–
15770.
The date of this meeting changed from
July 24–26, 2013 to September 18–19,
2013. The meeting is closed to the
public.
Dated: July 31, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–18895 Filed 8–5–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for Human
Genome Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: September 9–10, 2013.
BILLING CODE 4140–01–P
PO 00000
47715
Sfmt 4703
E:\FR\FM\06AUN1.SGM
06AUN1
47716
Federal Register / Vol. 78, No. 151 / Tuesday, August 6, 2013 / Notices
Closed: September 09, 2013, 8:30 a.m. to
10:00 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Terrace Level Conference Room, 5635 Fishers
Lane, Rockville, MD 20892.
Open: September 09, 2013, 10:00 a.m. to
4:00 p.m.
Agenda: To discuss matters of program
relevance.
Place: National Institutes of Health,
Terrace Level Conference Room, 5635 Fishers
Lane, Rockville, MD 20892.
Closed: September 10, 2013, 8:00 a.m. to
3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Smithsonian National Museum of
Natural History, 10th Street & Constitution
Avenue NW., Washington, DC 20560.
Contact Person: Comfort Browne, Program
Assistant, Division of Extramural Research,
National Human Genome Research Institute,
5635 Fishers Lane, Room 4076, Rockville,
MD 20892–9305, 301–496–7531,
cbrowne@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/11509849, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: July 31, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–18894 Filed 8–5–13; 8:45 am]
BILLING CODE 4140–01–P
Coast Guard
[Docket No. USCG–2012–1066]
Final Guidance Regarding Voluntary
Inspection of Vessels for Compliance
With the Maritime Labour Convention,
2006
Coast Guard, DHS.
Notice of availability .
AGENCY:
The Coast Guard announces
the availability of Navigation and Vessel
Inspection Circular (NVIC) 02–13, that
sets forth the Coast Guard’s policies and
procedures regarding the inspection of
U.S. vessels for voluntary compliance
with the Maritime Labour Convention,
2006 (MLC or Convention). The
Convention enters into force on August
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:47 Aug 05, 2013
A. Viewing the NVIC and Public
Comment Matrix
To view the NVIC, public comment
matrix, and comments mentioned in
this notice as being available in the
docket, please go to https://
www.regulations.gov, and follow the
instructions on that Web site. If you do
not have access to the internet, you may
view the docket online by visiting the
Docket Management Facility in Room
W12–140 on the ground floor of the
Department of Transportation West
Building, 1200 New Jersey Avenue SE.,
Washington, DC 20590, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays. We have an
agreement with the Department of
Transportation to use the Docket
Management Facility.
B. Background and Purpose
DEPARTMENT OF HOMELAND
SECURITY
ACTION:
20, 2013. The purpose of NVIC 02–13 is
to provide guidance to the maritime
industry, Coast Guard marine
inspectors, and other affected parties on
how the Coast Guard intends to
implement the new voluntary
inspection program. The Coast Guard
finalized NVIC 02–13 after considering
public comments received in response
to our publication of a draft version of
NVIC 02–13 in the Federal Register on
February 11, 2013.
FOR FURTHER INFORMATION CONTACT: If
you have questions on this notice, call
or email Lieutenant Commander
Christopher Gagnon, Coast Guard at cgcvc-1@uscg.mil; telephone 202–372–
1224. If you have questions on viewing
material in the docket, call Barbara
Hairston, Program Manager, Docket
Operations, telephone 202–366–9826.
SUPPLEMETARY INFORMATION:
Jkt 229001
The 94th (Maritime) session of the
International Labour Conference
(Geneva, February 2006) adopted the
MLC, a new international agreement
that consolidates almost all of the 70
existing International Labour
Organization maritime labour
instruments into a single, modern,
globally applicable legal instrument.
The Convention establishes
comprehensive minimum requirements
for working conditions of seafarers,
including, among other things,
conditions of employment, hours of
work and rest, accommodations,
recreational facilities, food and catering,
health protection, medical care, welfare,
and social security protection. It
combines rights and principles with
specific standards and detailed
guidance on how to implement these
standards at the national level. The
Convention is comprised of three
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
different, but related parts: the Articles,
the Regulations, and the Code. The
Articles and Regulations set out the core
rights and principles, and the basic
obligations of members ratifying the
Convention. The Code is comprised of
a Part A (mandatory standards) and a
Part B (non-mandatory guidelines).
To date, the U.S. Government has not
ratified the Convention. Unless and
until the U.S. Government ratifies the
Convention, the Coast Guard cannot
enforce Convention requirements on
U.S. vessels or foreign vessels while on
the navigable waters of the U.S. Article
V, paragraph 7 of the Convention
contains a ‘‘no more favorable treatment
clause,’’ which requires the
governments of ratifying nations to
impose Convention requirements on
vessels from non-ratifying nations. As a
result, a U.S. vessel that is not able to
demonstrate voluntary compliance with
the standards of the Convention may be
at risk for Port State Control actions
(including detention) when operating in
a port of a ratifying nation.
To assist owners and operators of U.S.
vessels in avoiding these risks, NVIC
02–13 sets forth guidance on a voluntary
inspection program for vessel owners/
operators who wish to document
compliance with the standards of the
MLC. U.S. commercial vessels that
operate on international routes, meaning
those vessels that will enter the ports of
countries that are parties to the MLC,
are encouraged to participate. Those
vessels not engaging on international
voyages are not affected.
In finalizing NVIC 02–13, the Coast
Guard utilized measures identified in
the MLC, including determinations that
vessels will be deemed compliant with
the MLC based on evidence of their
compliance with substantially
equivalent U.S. laws, regulations and
other measures. The Coast Guard’s use
of such equivalencies is intended to
help vessels streamline their
compliance efforts so that, where
appropriate, a vessel’s compliance with
domestic requirements also meets the
standards of the MLC.
Should the U.S. Government ratify the
MLC, its applicability may cover a
broader population of vessel owners/
operators than that addressed in NVIC
02–13. At that time, the Coast Guard
would consider whether new or revised
guidance is necessary.
C. Final NVIC and Response To
Comments
On February 11, 2013, the Coast
Guard published a notice in the Federal
Register announcing the availability of
a draft NVIC 02–13 and requesting
public comments. (See 78 FR 9709).
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 78, Number 151 (Tuesday, August 6, 2013)]
[Notices]
[Pages 47715-47716]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-18894]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council for Human Genome Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: September 9-10, 2013.
[[Page 47716]]
Closed: September 09, 2013, 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Terrace Level Conference
Room, 5635 Fishers Lane, Rockville, MD 20892.
Open: September 09, 2013, 10:00 a.m. to 4:00 p.m.
Agenda: To discuss matters of program relevance.
Place: National Institutes of Health, Terrace Level Conference
Room, 5635 Fishers Lane, Rockville, MD 20892.
Closed: September 10, 2013, 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: Smithsonian National Museum of Natural History, 10th
Street & Constitution Avenue NW., Washington, DC 20560.
Contact Person: Comfort Browne, Program Assistant, Division of
Extramural Research, National Human Genome Research Institute, 5635
Fishers Lane, Room 4076, Rockville, MD 20892-9305, 301-496-7531,
cbrowne@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.genome.gov/11509849, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: July 31, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-18894 Filed 8-5-13; 8:45 am]
BILLING CODE 4140-01-P
